CANCER CELL BIOLOGY TRAINING PROGRAM
CANCER CELL BIOLOGY TRAINING PROGRAM
批准号:
6949118
负责人:
CHANNING J. DER
金额:
$16.22万
依托单位国家:
美国
项目类别:
财政年份:
1996
资助国家:
美国
项目状态:
已结题
起止时间:
1996-09-30 至 2006-06-30
中文摘要
超出所提供的空间。本建议是为继续在查佩尔山的北卡罗来纳州大学(UNC-CH)为博士前学生提供跨学科的癌细胞生物学培训计划。该计划的前提是UNC-CH毕业的博士生在分子和细胞生物学的范式方面受到良好的训练,但这些学生很少接受癌症病理生物学和治疗方面的重要培训。随着越来越重视转化,疾病为导向的研究,需要解决这一不足,在研究生培养已成为更紧迫的。因此,该计划的广泛目标是提供癌症生物学的全面培训,使学生能够有效地为新一轮的转化研究做出贡献。该计划非常重视癌症的组织病理学和学员接触对肿瘤生物学至关重要的主题,包括血管生成,侵袭性,转移,癌症化疗和癌症药物发现。因此,它促进了博士候选人的培训,这些博士候选人经过独特的培训,并与UNC-CH的NIH资助的各个部门或其他培训项目明确区分开来。该计划由UNC-CH的卓越教师以及完善的Lineberger综合癌症中心(LCCC)提供的领导和计划补充。39名教师导师来自10个不同的UNC-CH部门和三个跨学科的博士前培训课程。项目指导员也是LCCC的成员。该培训计划的一个关键组成部分是建立癌细胞生物学课程,其中包括专门为计划学员开发的课程,这些课程涉及癌症病理学,诊断,药物发现和治疗中的关键问题。这个博士前课程是由已经为LCCC的长期博士后培训计划开发的计划的有力补充。因此,这两个培训项目共同促进了LCCC的目标,即创造一个全面、跨学科、有凝聚力和协作的研究环境,以促进博士前和博士后癌症研究人员的发展。性能现场=
英文摘要
EXCEED THE SPACE PROVIDED. This proposal is for continuation of an interdisciplinary Cancer Cell Biology Training Program for predoctoral ludents at the University of North Carolina at Chapel Hill (UNC-CH). The premise of this program is that the doctoral students graduated by UNC-CH are well trained in the paradigms of molecular and cellular biology, but rarely do these students receive significant training in the pathobiology and treatment of cancer. With an ncreasing emphasis on translational, disease-oriented research, the need to address this deficiency in graduate student training has become of greater urgency. Thus, the broad goal of this program is to provide comprehensive training in cancer biology to allow students to effectively contribute to the new wave of translational research. The program provides a strong emphasis on the histopathology of cancer and the exposure of trainees to topics crucial to tumor biology, including angiogenesis, invasiveness, metastasis, cancer chemotherapy, and cancer drug discovery. Therefore, it fosters the training of doctoral candidates that are uniquely trained and clearly distinguished from those of individual departments or other training programs funded by the NIH at UNC-CH. This program is complemented by the excellence of the faculty at UNC-CH and the leadership and programs provided by the well-established Lineberger Comprehensive Cancer Center (LCCC). The 39 faculty preceptors are drawn from 10 different UNC-CH departments and three interdisciplinary predoctoral training curricula. Program preceptors are also members of the LCCC. A critical component of this training program is the establishment of a Cancer Cell Biology Curriculum that includes coursework developed specifically for the Program trainees that address key issues in cancer pathology, diagnosis, drug discovery and treatment. This predoctoral program is strongly complemented by the programs that have been developed for the LCCC's long-standing postdoctoral training program. Thus, together, these two training programs facilitate the LCCC's goal to create a comprehensive, interdisciplinary, cohesive and collaborative research environment to foster the development of both pre- and postdoctoral cancer researchers. PERFORMANCE SITE ========================================Section End===========================================
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Project 1: Targeting autophagy for the treatment of KRAS-mutant PDAC
-
批准号:10705570
-
项目类别:
-
资助金额:$41.52万
-
财政年份:2022
-
负责人:CHANNING J. DER
-
依托单位:
Project 1: Targeting autophagy for the treatment of KRAS-mutant PDAC
-
批准号:10334083
-
项目类别:
-
资助金额:$46.76万
-
财政年份:2022
-
负责人:CHANNING J. DER
-
依托单位:
Targeting undruggable RAS for cancer treatment
-
批准号:9605901
-
项目类别:
-
资助金额:$90.92万
-
财政年份:2018
-
负责人:CHANNING J. DER
-
依托单位:
Targeting undruggable RAS for cancer treatment
-
批准号:10465051
-
项目类别:
-
资助金额:$90.0万
-
财政年份:2018
-
负责人:CHANNING J. DER
-
依托单位:
The Role of RHOA in Diffuse Gastric Cancer
-
批准号:10416081
-
项目类别:
-
资助金额:$78.78万
-
财政年份:2018
-
负责人:CHANNING J. DER
-
依托单位:
Targeting undruggable RAS for cancer treatment
-
批准号:10229383
-
项目类别:
-
资助金额:$92.1万
-
财政年份:2018
-
负责人:CHANNING J. DER
-
依托单位:
Targeting undruggable RAS for cancer treatment
-
批准号:10669038
-
项目类别:
-
资助金额:$90.25万
-
财政年份:2018
-
负责人:CHANNING J. DER
-
依托单位:
Defining RAS isoform- and mutation-specific roles in oncogenesis
-
批准号:9302699
-
项目类别:
-
资助金额:$154.24万
-
财政年份:2016
-
负责人:CHANNING J. DER
-
依托单位:
Defining RAS isoform- and mutation-specific roles in oncogenesis
-
批准号:9074404
-
项目类别:
-
资助金额:$160.97万
-
财政年份:2016
-
负责人:CHANNING J. DER
-
依托单位:
Administrative and biostatistics core
-
批准号:9074405
-
项目类别:
-
资助金额:$15.13万
-
财政年份:2016
-
负责人:CHANNING J. DER
-
依托单位:
Defining RAS isoform- and mutation-specific roles in oncogenesis
-
批准号:9982047
-
项目类别:
-
资助金额:$160.94万
-
财政年份:2016
-
负责人:CHANNING J. DER
-
依托单位:
Admin-Core-001
-
批准号:10025409
-
项目类别:
-
资助金额:$6.48万
-
财政年份:2016
-
负责人:CHANNING J. DER
-
依托单位:
ERK inhibitor resistance and ERK isoform-dependent growth in pancreatic cancer
-
批准号:8643960
-
项目类别:
-
资助金额:$23.19万
-
财政年份:2014
-
负责人:CHANNING J. DER
-
依托单位:
Mechanisms of PAK1 activation, signaling and tumor resistance
-
批准号:8639302
-
项目类别:
-
资助金额:$37.07万
-
财政年份:2014
-
负责人:CHANNING J. DER
-
依托单位:
Mechanisms of PAK1 activation, signaling and tumor resistance
-
批准号:8800547
-
项目类别:
-
资助金额:$36.19万
-
财政年份:2014
-
负责人:CHANNING J. DER
-
依托单位:
ERK inhibitor resistance and ERK isoform-dependent growth in pancreatic cancer
-
批准号:8787721
-
项目类别:
-
资助金额:$17.48万
-
财政年份:2014
-
负责人:CHANNING J. DER
-
依托单位:
Mechanisms of PAK1 activation, signaling and tumor resistance
-
批准号:8998934
-
项目类别:
-
资助金额:$42.43万
-
财政年份:2014
-
负责人:CHANNING J. DER
-
依托单位:
Genetic dissection and inhibitor targeting of Rac signaling in pancreatic cancer.
-
批准号:8178826
-
项目类别:
-
资助金额:$19.31万
-
财政年份:2011
-
负责人:CHANNING J. DER
-
依托单位:
Genetic dissection and inhibitor targeting of Rac signaling in pancreatic cancer.
-
批准号:8298169
-
项目类别:
-
资助金额:$16.1万
-
财政年份:2011
-
负责人:CHANNING J. DER
-
依托单位:
Validation of Inhibitors of RhoGTPases for Cancer Treatment
-
批准号:7882866
-
项目类别:
-
资助金额:$25.91万
-
财政年份:2009
-
负责人:CHANNING J. DER
-
依托单位:
国内基金
海外基金
登录
查看更多内容
全细胞疫苗Cell@MnO2的乳腺癌术后免疫响应监测与放射免疫治疗研究
-
批准号:QN25H220002
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:顾媛
-
依托单位:
染色体外环状DNA以cell-in-cell途径促进基因横向传递和扩增的研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:15.0万元
-
批准年份:2024
-
负责人:王锐智
-
依托单位:
GMFG/F-actin/cell adhesion 轴驱动 EHT 在造
血干细胞生成中的作用及机制研究
-
批准号:TGY24H080011
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2024
-
负责人:李鸿鹄
-
依托单位:
基于In-cell NMR策略对“舟楫之剂”桔梗中引经药效物质的快速发现研究
-
批准号:82305053
-
项目类别:青年科学基金项目
-
资助金额:30万元
-
批准年份:2023
-
负责人:王丽明
-
依托单位:
面向Cell-Free网络的协同虚拟化与动态传输
-
批准号:62371367
-
项目类别:面上项目
-
资助金额:49万元
-
批准年份:2023
-
负责人:陈健
-
依托单位:
Cell-in-cell促进曲妥珠单抗耐药乳腺癌细胞转移的作用与分子机制
-
批准号:82373069
-
项目类别:面上项目
-
资助金额:49万元
-
批准年份:2023
-
负责人:何美芳
-
依托单位:
基于Multi-Pass Cell的高功率皮秒激光脉冲非线性压缩关键技术研究
-
批准号:--
-
项目类别:青年科学基金项目
-
资助金额:30万元
-
批准年份:2022
-
负责人:宋贾俊
-
依托单位:
基于定点突变膜受体Cell-free合成生物色谱新方法的PDGFRβ抑制剂筛选和结合位点分析
-
批准号:82273886
-
项目类别:面上项目
-
资助金额:52万元
-
批准年份:2022
-
负责人:原永芳
-
依托单位:
FLRT3抑制异质性cell-in-cell结构形成机制及细胞免疫调节作用研究
-
批准号:--
-
项目类别:面上项目
-
资助金额:51万元
-
批准年份:2022
-
负责人:黄红艳
-
依托单位:
外泌体ORM1作为肿瘤免疫微环境中T细胞耗竭(T Cell Exhaustion)生物标志物及其功能研究
-
批准号:82102500
-
项目类别:青年科学基金项目(C类)
-
资助金额:30.0万元
-
批准年份:2021
-
负责人:杨阳
-
依托单位: